Mürşide Özpineci

Mürşide Özpineci

Auto-generated profile, based on publicly available information

Mürşide Özpineci

SANKO University Hospital, Gaziantep, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EDElif Dinler
Elif Dinler
DKDeniz Kocamaz
Deniz Kocamaz
MÖMürşide Özpineci
Mürşide Özpineci
SOSibel Polat Olca
Sibel Polat Olca
SISema İçEl
Sema İçEl
MYMustafa Yıldırım
Mustafa Yıldırım
This study investigates the relationship between cognitive function and depression in cancer patients receiving chemotherapy. A cross-sectional study design was employed, involving 80 cancer patients undergoing chemotherapy. Data were collected using the Socio-Demographic Information Form, the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog), and the Beck Depression Inventory (BDI). Assessments were conducted prior to the second cycle of chemotherapy. Among participants, 72.8% were female and 47.5% aged 40–50. Moderate depressive symptoms were most common (45%). Cognitive dysfunction was inversely correlated with depression (r = -0.525, p < 0.001). Low income significantly predicted lower cognitive scores (p = 0.01). Chemotherapy patients exhibit cognitive decline and elevated depression levels. Socioeconomic status exacerbates these effects. Psychosocial interventions should be integrated into oncological rehabilitation.